Sio Gene Therapies Inc.
USD0.48
+0.09 (+22.63%)
CEO
David W. Nassif
IPO Date
2015-06-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.38
Prev. Close
$0.39
Day Low
$0.38
Day High
$0.48
52W Low
$0.25
52W High
$0.50
Volume
0.01M
| 37,567 |
| $0.00 |
| 9 Dec 2021 | Cheruvu Pavan | director, officer: Chief Executive Officer | F-InKind | Disposed | 14,884 | $1.42 |
| 9 Dec 2021 | Cheruvu Pavan | director, officer: Chief Executive Officer | D-Return | Disposed | 37,567 | $0.00 |
| 9 Dec 2021 | Nassif David W. | Chief Financial Officer | A-Award | Acquired | 17,534 | $0.00 |
| 9 Dec 2021 | Nassif David W. | Chief Financial Officer | F-InKind | Disposed | 6,294 | $1.42 |
| 9 Dec 2021 | Nassif David W. | Chief Financial Officer | D-Return | Disposed | 17,534 | $0.00 |
| 19 Apr 2021 | Pande Atul | director | A-Award | Acquired | 42,000 | $2.47 |
| 19 Apr 2021 | Modig Berndt | director | A-Award | Acquired | 42,000 | $2.47 |
| 19 Apr 2021 | Cheruvu Pavan | director, officer: Chief Executive Officer | A-Award | Acquired | 682,100 | $2.47 |